|
1
|
Chi AC, Day TA and Neville BW: Oral cavity
and oropharyngeal squamous cell carcinoma–an update. CA Cancer J
Clin. 65:401–421. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Warnakulasuriya S: Global epidemiology of
oral and oropharyngeal cancer. Oral Oncol. 45:309–316. 2009.
View Article : Google Scholar
|
|
6
|
Sano D and Myers JN: Metastasis of
squamous cell carcinoma of the oral tongue. Cancer Metastasis Rev.
26:645–662. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ng JH, Iyer NG, Tan MH and Edgren G:
Changing epidemiology of oral squamous cell carcinoma of the
tongue: A global study. Head Neck. 39:297–304. 2017. View Article : Google Scholar
|
|
8
|
Patel SC, Carpenter WR, Tyree S, Couch ME,
Weissler M, Hackman T, Hayes DN, Shores C and Chera BS: Increasing
incidence of oral tongue squamous cell carcinoma in young white
women, age 18 to 44 years. J Clin Oncol. 29:1488–1494. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pavia M, Pileggi C, Nobile CG and
Angelillo IF: Association between fruit and vegetable consumption
and oral cancer: A meta-analysis of observational studies. Am J
Clin Nutr. 83:1126–1134. 2006.PubMed/NCBI
|
|
10
|
Khan N, Afaq F and Mukhtar H: Cancer
chemoprevention through dietary antioxidants: Progress and promise.
Antioxid Redox Signal. 10:475–510. 2008. View Article : Google Scholar
|
|
11
|
Weng CJ and Yen GC: Chemopreventive
effects of dietary phytochemicals against cancer invasion and
metastasis: Phenolic acids, monophenol, polyphenol, and their
derivatives. Cancer Treat Rev. 38:76–87. 2012. View Article : Google Scholar
|
|
12
|
Gonçalves VP, Ortega AA, Guimarães MR,
Curylofo FA, Rossa Junior C, Ribeiro DA and Spolidorio LC:
Chemopreventive activity of systemically administered curcumin on
oral cancer in the 4-nitroquinoline 1-oxide model. J Cell Biochem.
116:787–796. 2015. View Article : Google Scholar
|
|
13
|
Zlotogorski A, Dayan A, Dayan D, Chaushu
G, Salo T and Vered M: Nutraceuticals as new treatment approaches
for oral cancer: I. Curcumin. Oral Oncol. 49:187–191. 2013.
View Article : Google Scholar
|
|
14
|
Iriti M and Varoni EM: Chemopreventive
potential of flavonoids in oral squamous cell carcinoma in human
studies. Nutrients. 5:2564–2576. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zlotogorski A, Dayan A, Dayan D, Chaushu
G, Salo T and Vered M: Nutraceuticals as new treatment approaches
for oral cancer: II. Green tea extracts and resveratrol. Oral
Oncol. 49:502–506. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Silva RC, Rigaud J, Cheynier V and Chemina
A: Procyanidin dimers and trimers from grape seeds. Phytochemistry.
30:1259–1264. 1991. View Article : Google Scholar
|
|
17
|
Prieur C, Rigaud J, Cheynier V and
Moutounet M: Oligomeric and polymeric procyanidins from grape
seeds. Phytochemistry. 36:781–789. 1994. View Article : Google Scholar
|
|
18
|
Nandakumar V, Singh T and Katiyar SK:
Multi-targeted prevention and therapy of cancer by
proanthocyanidins. Cancer Lett. 269:378–387. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kaur M, Agarwal C and Agarwal R:
Anticancer and cancer chemopreventive potential of grape seed
extract and other grape-based products. J Nutr. 139:1806S–1812S.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Katiyar SK and Athar M: Grape seeds: Ripe
for cancer chemoprevention. Cancer Prev Res (Phila). 6:617–621.
2013. View Article : Google Scholar
|
|
21
|
Chatelain K, Phippen S, McCabe J, Teeters
CA, O'Malley S and Kingsley K: Cranberry and grape seed extracts
inhibit the proliferative phenotype of oral squamous cell
carcinomas. Evid Based Complement Alternat Med. 2011:4676912011.
View Article : Google Scholar :
|
|
22
|
Lin YS, Chen SF, Liu CL and Nieh S: The
chemoadjuvant potential of grape seed procyanidins on p53-related
cell death in oral cancer cells. J Oral Pathol Med. 41:322–331.
2012. View Article : Google Scholar
|
|
23
|
Aghbali A, Hosseini SV, Delazar A, Gharavi
NK, Shahneh FZ, Orangi M, Bandehagh A and Baradaran B: Induction of
apoptosis by grape seed extract (Vitis vinifera) in oral squamous
cell carcinoma. Bosn J Basic Med Sci. 13:186–191. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sun Q, Prasad R, Rosenthal E and Katiyar
SK: Grape seed proanthocyanidins inhibit the invasiveness of human
HNSCC cells by targeting EGFR and reversing the
epithelial-to-mesenchymal transition. PLoS One. 7:e310932012.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yen CY, Hou MF, Yang ZW, Tang JY, Li KT,
Huang HW, Huang YH, Lee SY, Fu TF, Hsieh CY, et al: Concentration
effects of grape seed extracts in anti-oral cancer cells involving
differential apoptosis, oxidative stress, and DNA damage. BMC
Complement Altern Med. 15:942015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shrotriya S, Tyagi A, Deep G, Orlicky DJ,
Wisell J, Wang XJ, Sclafani RA, Agarwal R and Agarwal C: Grape seed
extract and resveratrol prevent 4-nitroquinoline 1-oxide induced
oral tumorigenesis in mice by modulating AMPK activation and
associated biological responses. Mol Carcinog. 54:291–300. 2015.
View Article : Google Scholar
|
|
27
|
Vichai V and Kirtikara K: Sulforhodamine B
colorimetric assay for cytotoxicity screening. Nat Protoc.
1:1112–1116. 2006. View Article : Google Scholar
|
|
28
|
Huang S, Yang N, Liu Y, Hu L, Zhao J, Gao
J, Li Y, Li C, Zhang X and Huang T: Grape seed proanthocyanidins
inhibit angiogenesis via the downregulation of both vascular
endothelial growth factor and angiopoietin signaling. Nutr Res.
32:530–536. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Albini A, Iwamoto Y, Kleinman HK, Martin
GR, Aaronson SA, Kozlowski JM and McEwan RN: A rapid in vitro assay
for quantitating the invasive potential of tumor cells. Cancer Res.
47:3239–3245. 1987.PubMed/NCBI
|
|
30
|
Dogan E, Cetinayak HO, Sarioglu S, Erdag
TK and Ikiz AO: Patterns of cervical lymph node metastases in oral
tongue squamous cell carcinoma: Implications for elective and
therapeutic neck dissection. J Laryngol Otol. 128:268–273. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fraga CG and Oteiza PI: Dietary
flavonoids: Role of (−)-epicatechin and related procyanidins in
cell signaling. Free Radic Biol Med. 51:813–823. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bagchi D, Swaroop A, Preuss HG and Bagchi
M: Free radical scavenging, antioxidant and cancer chemoprevention
by grape seed proanthocyanidin: An overview. Mutat Res. 768:69–73.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Delbridge AR, Grabow S, Strasser A and
Vaux DL: Thirty years of BCL-2: Translating cell death discoveries
into novel cancer therapies. Nat Rev Cancer. 16:99–109. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Siddiqui WA, Ahad A and Ahsan H: The
mystery of BCL2 family: Bcl-2 proteins and apoptosis: an update.
Arch Toxicol. 89:289–317. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wan L, Pantel K and Kang Y: Tumor
metastasis: Moving new biological insights into the clinic. Nat
Med. 19:1450–1464. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Martini M, De Santis MC, Braccini L,
Gulluni F and Hirsch E: PI3K/AKT signaling pathway and cancer: An
updated review. Ann Med. 46:372–383. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tokunaga E, Oki E, Egashira A, Sadanaga N,
Morita M, Kakeji Y and Maehara Y: Deregulation of the Akt pathway
in human cancer. Curr Cancer Drug Targets. 8:27–36. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Manning BD and Cantley LC: AKT/PKB
signaling: Navigating downstream. Cell. 129:1261–1274. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ozes ON, Mayo LD, Gustin JA, Pfeffer SR,
Pfeffer LM and Donner DB: NF-kappaB activation by tumour necrosis
factor requires the Akt serine-threonine kinase. Nature. 401:82–85.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Dolcet X, Llobet D, Pallares J and
Matias-Guiu X: NF-kB in development and progression of human
cancer. Virchows Arch. 446:475–482. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Oeckinghaus A, Hayden MS, Ghosh S and
Matias-Guiu X: Crosstalk in NF-κB signaling pathways. Nat Immunol.
12:695–708. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Nakayama H, Ikebe T, Beppu M and Shirasuna
K: High expression levels of nuclear factor kappaB, IkappaB kinase
alpha and Akt kinase in squamous cell carcinoma of the oral cavity.
Cancer. 92:3037–3044. 2001. View Article : Google Scholar : PubMed/NCBI
|
